Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (11-20 of 260) with videos related to

Pageof 26
Sort By:
Clinical Transplants|August 7, 2014
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Reply to S. FujiMark J Levis, Mehdi Hamadani, Mary M Horowitz, et al.
Clinical Transplants|June 24, 2011
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo C Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in ChildrenWael Saber, Mei-Jie Zhang, Patricia Steinert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donorsRene Duquesnoy, Stephen Spellman, Michael Haagenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
On the probability of using cord bloodJ J Nietfeld, Marcelo C Pasquini, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Lifetime probabilities of hematopoietic stem cell transplantation in the U.SJ J Nietfeld, Marcelo C Pasquini, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2002
Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantationPaul J Martin, Joseph H Antin, Daniel J Weisdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2019
FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical?Mark J Levis, Yi-Bin Chen, Mehdi Hamadani, et al.
Blood|February 14, 2012
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemiaWael Saber, Shaun Opie, J Douglas Rizzo, et al.
Pageof 26

Showing results (11-20 of 260) with videos related to

Sort By:
Pageof 26
Clinical Transplants|August 7, 2014
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Reply to S. FujiMark J Levis, Mehdi Hamadani, Mary M Horowitz, et al.
Clinical Transplants|June 24, 2011
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo C Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in ChildrenWael Saber, Mei-Jie Zhang, Patricia Steinert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donorsRene Duquesnoy, Stephen Spellman, Michael Haagenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
On the probability of using cord bloodJ J Nietfeld, Marcelo C Pasquini, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Lifetime probabilities of hematopoietic stem cell transplantation in the U.SJ J Nietfeld, Marcelo C Pasquini, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2002
Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantationPaul J Martin, Joseph H Antin, Daniel J Weisdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2019
FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical?Mark J Levis, Yi-Bin Chen, Mehdi Hamadani, et al.
Blood|February 14, 2012
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemiaWael Saber, Shaun Opie, J Douglas Rizzo, et al.
Pageof 26